Trademark: 88901543
Word
SOLYMBIC
Status
Dead
Status Code
606
Status Date
Monday, April 17, 2023
Serial Number
88901543
Mark Type
4000
Filing Date
Tuesday, May 5, 2020
Published for Opposition
Tuesday, July 21, 2020
Abandoned Date
Monday, April 17, 2023

Trademark Owner History
Amgen Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Trademark Events
Apr 17, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 17, 2023
Abandonment - No Use Statement Filed
Sep 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 15, 2022
Sou Extension 4 Granted
Sep 15, 2022
Sou Extension 4 Filed
Sep 15, 2022
Teas Extension Received
Mar 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2022
Sou Extension 3 Granted
Mar 15, 2022
Sou Extension 3 Filed
Mar 15, 2022
Teas Extension Received
Aug 14, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2021
Sou Extension 2 Granted
Aug 12, 2021
Sou Extension 2 Filed
Aug 12, 2021
Teas Extension Received
Mar 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2021
Sou Extension 1 Granted
Mar 15, 2021
Sou Extension 1 Filed
Mar 15, 2021
Teas Extension Received
Sep 15, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 21, 2020
Published For Opposition
Jul 1, 2020
Notification Of Notice Of Publication E-Mailed
Jun 15, 2020
Approved For Pub - Principal Register
May 29, 2020
Examiner's Amendment Entered
May 29, 2020
Notification Of Examiners Amendment E-Mailed
May 29, 2020
Examiners Amendment E-Mailed
May 29, 2020
Examiners Amendment -Written
May 25, 2020
Assigned To Examiner
May 15, 2020
New Application Office Supplied Data Entered
May 8, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24